This research demonstrates feedback loops enhance adaptability and competitive advantage in Indonesia's pharmaceutical industry.
Innovation in the pharmaceutical industry is increasingly recognized as a systemic and interdependent process that requires holistic coordination across technological, organizational, and marketing domains. This study examines the structural interrelationships among six dimensions of marketing innovation—process, product, organization, price, promotion, and distribution—within Indonesia’s pharmaceutical sector. Using Fuzzy Interpretive Structural Modeling (Fuzzy ISM), expert evaluations from clinical, industrial, and regulatory professionals were analyzed to identify causal linkages and feedback loops that characterize sustainable innovation systems. The results show that marketing innovation functions not as a hierarchical structure but as a dynamic, circular configuration termed the Integrated Cycle Model of Sustainable Marketing Innovation. Each dimension simultaneously acts as both a driver and a dependent element, forming continuous reciprocal interactions that enhance adaptability, strategic resilience, and competitive advantage. The absence of a dominant driver highlights the need for systemic orchestration rather than isolated innovation initiatives. The study advances systemic innovation theory by demonstrating that sustainability in pharmaceutical marketing emerges from multidirectional feedback and balanced capability alignment across all innovation dimensions. The Integrated Cycle Model offers theoretical and managerial insights for designing coordinated innovation strategies and policy frameworks that support sustainable growth in emerging markets.
No takes yet. Share an insight, caveat, or question.
Zuldekra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: